Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03433300 · ClinicalTrials.gov registry record · NA

Microprocessor Knees in Early Rehabilitation

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03433300 is a NA study that has completed, run by University of Washington. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03433300, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

High-quality, empirical evidence to guide prosthetic rehabilitation following amputation ensures that Service members, Veterans, and civilians who experience limb loss have the potential to receive the highest quality care, regain mobility, return to gainful employment, and reintegrate into their communities. However, evidence to inform prosthetic care during the crucial post-amputation period is extremely limited. The proposed research will address this gap in knowledge by evaluating functional and patient-centered health outcomes associated with use of two distinct prosthetic knee technologies in early rehabilitation following transfemoral amputation. This novel, comparative effectiveness research aligns with the Prosthetic Outcomes Research Award (PORA) focus area of understanding the management of patient rehabilitation strategies throughout the rehabilitation process following neuromuscular injury. The long-term goals of this project are to optimize early rehabilitation processes and associated outcomes for Service members, Veterans, and civilians with lower limb amputation. The purpose of this study is to evaluate the potential for different prosthetic knee technologies to promote function, health, and quality of life following amputation. A pilot randomized controlled trial will be conducted to compare falls, step activity, balance confidence, mobility, health-related quality of life, and community integration of people with recent transfemoral amputation in two prosthetic knee conditions: a microprocessor knee (MPK) with control of stance phase and a non-microprocessor knee (NMPK) that is appropriate for people in early rehabilitation.

Interventions

  • DEVICE Ottobock Kenevo/C-Leg
  • DEVICE Ottobock 3R60/3R62

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-04-13
Est. Completion 2020-05-15
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT03433300

The ClinicalTrials.gov registry entry for NCT03433300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ottobock Kenevo/C-Leg is the first listed.

NCT03433300 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03433300 about?

NCT03433300 is a clinical study titled "Microprocessor Knees in Early Rehabilitation". High-quality, empirical evidence to guide prosthetic rehabilitation following amputation ensures that Service members, Veterans, and civilians who experience limb loss have the potential to receive the highest quality care, regain mobility, return to gainful employment, and reintegrate into their co...

What is the current status of trial NCT03433300?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-04-13. Estimated completion is 2020-05-15.

What interventions are being tested in trial NCT03433300?

The interventions under investigation include: Ottobock Kenevo/C-Leg (DEVICE), Ottobock 3R60/3R62 (DEVICE).

Who is sponsoring clinical trial NCT03433300?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.